Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS) - Summary - MDSpire

Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)

  • By

  • Maurizio De Luca

  • Scott Shikora

  • Dan Eisenberg

  • Luigi Angrisani

  • Chetan Parmar

  • Aayed Alqahtani

  • Ali Aminian

  • Edo Aarts

  • Wendy Brown

  • Ricardo V. Cohen

  • Nicola Di Lorenzo

  • Silvia L. Faria

  • Kasey P. S. Goodpaster

  • Ashraf Haddad

  • Miguel Herrera

  • Raul Rosenthal

  • Jacques Himpens

  • Angelo Iossa

  • Mohammad Kermansaravi

  • Lilian Kow

  • Marina Kurian

  • Sonja Chiappetta

  • Teresa LaMasters

  • Kamal Mahawar

  • Giovanni Merola

  • Abdelrahman Nimeri

  • Mary O’Kane

  • Pavlos Papasavas

  • Giacomo Piatto

  • Jaime Ponce

  • Gerhard Prager

  • Janey S. A. Pratt

  • Ann M. Rogers

  • Paulina Salminen

  • Kimberley E. Steele

  • Michel Suter

  • Salvatore Tolone

  • Antonio Vitiello

  • Marco Zappa

  • Shanu N. Kothari

  • September 25, 2024

  • 0 min

Share

Objective:

To revise the outdated 1991 NIH guidelines for metabolic and bariatric surgery (MBS) based on current evidence and practices, ensuring improved patient outcomes.

Key Findings:
  • The 1991 NIH guidelines are outdated and do not reflect current practices in MBS, necessitating a revision.
  • New recommendations were developed for patients with BMI 30–34.9 kg/m2 and those with BMI 35–40 kg/m2, enhancing treatment options.
  • MBS is recommended for patients with T2DM and a BMI of 30–34.9 kg/m2, indicating a shift towards more inclusive criteria.
Interpretation:

The updated guidelines provide a more evidence-based approach to patient selection for MBS, improving the potential for better outcomes.

Limitations:
  • Some statements lacked sufficient literature support, necessitating reliance on expert opinion, which may affect guideline robustness.
  • The systematic reviews did not cover all potential criteria for MBS, indicating areas for future research.
Conclusion:

The collaboration between ASMBS and IFSO has led to the establishment of updated, evidence-based guidelines for MBS, significantly enhancing patient care and outcomes.

Original Source(s)

Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)

  • by Maurizio De Luca, Scott Shikora, Dan Eisenberg, Luigi Angrisani, Chetan Parmar, Aayed Alqahtani, Ali Aminian, Edo Aarts, Wendy Brown, Ricardo V. Cohen, Nicola Di Lorenzo, Silvia L. Faria, Kasey P. S. Goodpaster, Ashraf Haddad, Miguel Herrera, Raul Rosenthal, Jacques Himpens, Angelo Iossa, Mohammad Kermansaravi, Lilian Kow, Marina Kurian, Sonja Chiappetta, Teresa LaMasters, Kamal Mahawar, Giovanni Merola, Abdelrahman Nimeri, Mary O’Kane, Pavlos Papasavas, Giacomo Piatto, Jaime Ponce, Gerhard Prager, Janey S. A. Pratt, Ann M. Rogers, Paulina Salminen, Kimberley E. Steele, Michel Suter, Salvatore Tolone, Antonio Vitiello, Marco Zappa, Shanu N. Kothari

  • September 25, 2024

Related Content

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial

FOXC1 Duplications Linked to Early-Onset Glaucoma

FOXC1 duplications were the second most common monogenic finding among genetically solved juvenile open-angle glaucoma cases in one registry, supporting the use of copy-number variant analysis in early-onset glaucoma testing.

Fluoroscopy-guided removal of a migrated non-palpable implanon adherent to the ulnar nerve: a case report